Indian drugmaker Ranbaxy faces new US regulation woes (Update 2)
Shares in Indian generic drugs giant Ranbaxy Laboratories crashed by as much as 35 percent on Monday after the US Food and Drug Administration suspended imports from one of its factories.
Sep 16, 2013
0
0